Market Cap 88.80M
Revenue (ttm) 0.00
Net Income (ttm) -10.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 599,800
Avg Vol 131,626
Day's Range N/A - N/A
Shares Out 34.02M
Stochastic %K 95%
Beta 0.59
Analysts Strong Sell
Price Target $10.00

Company Profile

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery pro...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 708 9808
Address:
3150 Almaden Expressway, Suite 250, San Jose, United States
Stocktradexxx
Stocktradexxx Jun. 17 at 3:54 PM
$ANIX another insider buy by Anixa's director Titterton https://ir.anixa.com/sec-filings/content/0001493152-26-029030/ownership.html
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jun. 17 at 3:44 PM
🚨 $CUE : Can Recent Milestones Fuel the Next Breakout? 📈 CUE continues to show strength, holding its rising trendline as buyers defend higher lows near key support levels. Traders are now watching to see if the stock can reclaim key resistance levels and trigger the next leg higher. Technical View: 🔹 Higher lows continue to develop 🔹 Rising trendline remains intact Key Levels to Watch: 📈 Support ➡️ $25.34 📈 Trend Support ➡️ $29.13 📈 Resistance Zone ➡️ $32.90–$34.25 📈 Breakout Trigger ➡️ $37.27 Recent company milestones include a major board transition with the addition of experienced biotech leaders Daniel Camardo and Viola Meehan, further strengthening the company's leadership team Meanwhile, the company continues advancing CUE-401 and its broader autoimmune disease pipeline, giving investors several potential catalysts to watch moving forward Communicated Disclaimer: stockresearchtoday.com/cue/ Sector Peers: $ACHV $ANIX $TCRT $INNM
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jun. 17 at 2:17 PM
🚨$CUE : Can Recent Milestones Fuel the Next Breakout? 📈 CUE continues to show strength, holding its rising trendline as buyers defend higher lows near key support levels. Traders are now watching to see if the stock can reclaim key resistance levels and trigger the next leg higher. Technical View: 🔹 Higher lows continue to develop 🔹 Rising trendline remains intact Key Levels to Watch: 📈 Support ➡️ $25.34 📈 Trend Support ➡️ $29.13 📈 Resistance Zone ➡️ $32.90–$34.25 📈 Breakout Trigger ➡️ $37.27 📈 Momentum Target ➡️ $45+ Recent company milestones include a major board transition with the addition of experienced biotech leaders Daniel Camardo and Viola Meehan, further strengthening the company's leadership team Meanwhile, the company continues advancing CUE-401 and its broader autoimmune disease pipeline, giving investors several potential catalysts to watch moving forward Communicated Disclaimer: https://stockresearchtoday.com/cue/ Sector Peers: $ACHV $ANIX $TCRT
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 16 at 3:05 PM
$ANIX CEO purchased 21,000 shares at $2.50 for a total of $52,500. KUMAR AMIT now owns 630,812 shares. https://ceo-buys.com
0 · Reply
typevoid
typevoid Jun. 16 at 3:04 PM
$ANIX CEO Kumar Amit purchased 21,000 shares at $2.50, a total investment of $52,500. check out the filing: http://s.founcha.com/vQxJ5
0 · Reply
Stocktradexxx
Stocktradexxx Jun. 16 at 1:25 PM
$ANIX Looks like CEO Amit just picked up some more shares https://ir.anixa.com/sec-filings/content/0001493152-26-028827/ownership.html
0 · Reply
jpurr
jpurr Jun. 11 at 7:55 PM
$ANIX I have a new theory. ANIX is trying to bore cancer to death.
1 · Reply
focafoca99
focafoca99 Jun. 11 at 1:39 PM
$ANIX released news of two clinical-stage immunotherapy presentations at the Frontiers in Cancer Immunotherapy symposium, highlighting its
0 · Reply
2maligators
2maligators Jun. 10 at 4:45 PM
$ANIX buy in at 2.38?
1 · Reply
Investerare_SAAB
Investerare_SAAB Jun. 1 at 2:04 PM
$RZLV $ANIX both to the moon soon...❤️
0 · Reply
Latest News on ANIX
Anixa Biosciences Quarterly report: Q2 2026

Jun 10, 2026, 7:00 AM EDT - 8 days ago

Anixa Biosciences Quarterly report: Q2 2026


Anixa Biosciences Slides: Corporate presentation

Jun 4, 2026, 7:00 AM EDT - 14 days ago

Anixa Biosciences Slides: Corporate presentation


Anixa Biosciences: CIPO issues Notice of Allowance for patent

2026-06-01T14:17:37.000Z - 17 days ago

Anixa Biosciences: CIPO issues Notice of Allowance for patent


Anixa Biosciences Slides: Corporate presentation

Apr 14, 2026, 7:00 AM EDT - 2 months ago

Anixa Biosciences Slides: Corporate presentation


Anixa Biosciences announces agreement with Cytovance Biologics

2026-04-01T12:59:01.000Z - 2 months ago

Anixa Biosciences announces agreement with Cytovance Biologics


Anixa Biosciences Transcript: AGM 2026

Mar 10, 2026, 1:00 PM EDT - 3 months ago

Anixa Biosciences Transcript: AGM 2026


Anixa Biosciences Slides: FY 2026

Mar 10, 2026, 1:00 PM EDT - 3 months ago

Anixa Biosciences Slides: FY 2026


Anixa Biosciences Slides: Corporate presentation

Mar 10, 2026, 7:00 AM EDT - 3 months ago

Anixa Biosciences Slides: Corporate presentation


Anixa Biosciences Quarterly report: Q1 2026

Mar 9, 2026, 7:00 AM EDT - 3 months ago

Anixa Biosciences Quarterly report: Q1 2026


Anixa Biosciences Transcript: Fireside chat

Feb 10, 2026, 11:00 AM EST - 4 months ago

Anixa Biosciences Transcript: Fireside chat


Anixa Biosciences Press release: Fireside chat

Feb 10, 2026, 11:00 AM EST - 4 months ago

Anixa Biosciences Press release: Fireside chat


Anixa Biosciences Slides: Corporate presentation

Feb 7, 2026, 6:00 AM EST - 4 months ago

Anixa Biosciences Slides: Corporate presentation


Anixa Biosciences Proxy statement: Proxy Filing

Jan 28, 2026, 7:00 AM EST - 5 months ago

Anixa Biosciences Proxy statement: Proxy Filing


Anixa Biosciences Slides: Investor presentation

Jan 16, 2026, 7:00 AM EST - 5 months ago

Anixa Biosciences Slides: Investor presentation


Anixa Biosciences Annual report: Q4 2025

Jan 12, 2026, 7:00 AM EST - 5 months ago

Anixa Biosciences Annual report: Q4 2025


Anixa Biosciences Slides: Corporate Presentation

Nov 17, 2025, 7:00 AM EST - 7 months ago

Anixa Biosciences Slides: Corporate Presentation


Anixa Biosciences Transcript: Fireside Chat

Nov 11, 2025, 2:00 PM EST - 7 months ago

Anixa Biosciences Transcript: Fireside Chat


Anixa Biosciences executes data transfer with Cleveland Clinic

2025-11-05T14:01:35.000Z - 8 months ago

Anixa Biosciences executes data transfer with Cleveland Clinic


Anixa Biosciences files $200M mixed securities shelf

2025-09-10T21:30:21.000Z - 10 months ago

Anixa Biosciences files $200M mixed securities shelf


Anixa Biosciences Registration statement: Registration Filing

Sep 10, 2025, 8:00 AM EDT - 10 months ago

Anixa Biosciences Registration statement: Registration Filing


Anixa Biosciences Quarterly report: Q3 2025

Sep 10, 2025, 7:00 AM EDT - 10 months ago

Anixa Biosciences Quarterly report: Q3 2025


Anixa Biosciences Transcript: Status Update

Jun 26, 2025, 2:00 PM EDT - 1 year ago

Anixa Biosciences Transcript: Status Update


Anixa Biosciences Quarterly report: Q2 2025

May 28, 2025, 4:00 PM EDT - 1 year ago

Anixa Biosciences Quarterly report: Q2 2025


Stocktradexxx
Stocktradexxx Jun. 17 at 3:54 PM
$ANIX another insider buy by Anixa's director Titterton https://ir.anixa.com/sec-filings/content/0001493152-26-029030/ownership.html
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jun. 17 at 3:44 PM
🚨 $CUE : Can Recent Milestones Fuel the Next Breakout? 📈 CUE continues to show strength, holding its rising trendline as buyers defend higher lows near key support levels. Traders are now watching to see if the stock can reclaim key resistance levels and trigger the next leg higher. Technical View: 🔹 Higher lows continue to develop 🔹 Rising trendline remains intact Key Levels to Watch: 📈 Support ➡️ $25.34 📈 Trend Support ➡️ $29.13 📈 Resistance Zone ➡️ $32.90–$34.25 📈 Breakout Trigger ➡️ $37.27 Recent company milestones include a major board transition with the addition of experienced biotech leaders Daniel Camardo and Viola Meehan, further strengthening the company's leadership team Meanwhile, the company continues advancing CUE-401 and its broader autoimmune disease pipeline, giving investors several potential catalysts to watch moving forward Communicated Disclaimer: stockresearchtoday.com/cue/ Sector Peers: $ACHV $ANIX $TCRT $INNM
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jun. 17 at 2:17 PM
🚨$CUE : Can Recent Milestones Fuel the Next Breakout? 📈 CUE continues to show strength, holding its rising trendline as buyers defend higher lows near key support levels. Traders are now watching to see if the stock can reclaim key resistance levels and trigger the next leg higher. Technical View: 🔹 Higher lows continue to develop 🔹 Rising trendline remains intact Key Levels to Watch: 📈 Support ➡️ $25.34 📈 Trend Support ➡️ $29.13 📈 Resistance Zone ➡️ $32.90–$34.25 📈 Breakout Trigger ➡️ $37.27 📈 Momentum Target ➡️ $45+ Recent company milestones include a major board transition with the addition of experienced biotech leaders Daniel Camardo and Viola Meehan, further strengthening the company's leadership team Meanwhile, the company continues advancing CUE-401 and its broader autoimmune disease pipeline, giving investors several potential catalysts to watch moving forward Communicated Disclaimer: https://stockresearchtoday.com/cue/ Sector Peers: $ACHV $ANIX $TCRT
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 16 at 3:05 PM
$ANIX CEO purchased 21,000 shares at $2.50 for a total of $52,500. KUMAR AMIT now owns 630,812 shares. https://ceo-buys.com
0 · Reply
typevoid
typevoid Jun. 16 at 3:04 PM
$ANIX CEO Kumar Amit purchased 21,000 shares at $2.50, a total investment of $52,500. check out the filing: http://s.founcha.com/vQxJ5
0 · Reply
Stocktradexxx
Stocktradexxx Jun. 16 at 1:25 PM
$ANIX Looks like CEO Amit just picked up some more shares https://ir.anixa.com/sec-filings/content/0001493152-26-028827/ownership.html
0 · Reply
jpurr
jpurr Jun. 11 at 7:55 PM
$ANIX I have a new theory. ANIX is trying to bore cancer to death.
1 · Reply
focafoca99
focafoca99 Jun. 11 at 1:39 PM
$ANIX released news of two clinical-stage immunotherapy presentations at the Frontiers in Cancer Immunotherapy symposium, highlighting its
0 · Reply
2maligators
2maligators Jun. 10 at 4:45 PM
$ANIX buy in at 2.38?
1 · Reply
Investerare_SAAB
Investerare_SAAB Jun. 1 at 2:04 PM
$RZLV $ANIX both to the moon soon...❤️
0 · Reply
Rideabull
Rideabull May. 28 at 2:18 PM
$ANIX I have been in this stock for 3+ years and underwater for 1+. I have a large holding and have resisted dumping it, but my patience is wearing thin. In the absence of a partnership, this will float along sub $3.00 for the foreseeable future. Am I missing something?
2 · Reply
SuperGreenToday
SuperGreenToday May. 14 at 4:03 AM
$ANIX Share Price: $2.91 Contract Selected: Oct 16, 2026 $2.5 Calls Buy Zone: $1.01 – $1.25 Target Zone: $1.67 – $2.04 Potential Upside: 56% ROI Time to Expiration: 155 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
bioinvestorrr
bioinvestorrr May. 11 at 1:24 PM
$ANIX great news, curious to see movement
1 · Reply
Kher33
Kher33 May. 11 at 12:56 PM
0 · Reply
Stock_Catcher
Stock_Catcher May. 11 at 12:55 PM
$ANIX Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy
0 · Reply
justiceforb_85
justiceforb_85 May. 8 at 3:34 AM
$ANIX when is their next clinical update on the breast cancer vaccine? Science behind it is intriguing but it's extremely early stage.
0 · Reply
Stocktradexxx
Stocktradexxx May. 4 at 8:18 PM
$ANIX great article highlighting Anixa's breast cancer vaccine- https://www.wptv.com/news/treasure-coast/patient-who-received-breast-cancer-vaccine-as-part-of-clinical-trial-speaks-about-experience
0 · Reply
SCUBus
SCUBus May. 2 at 7:52 PM
$ANIX Anybody else planning to watch CEO Amit Kumar speak on Bloomberg TV tonight between 7 - 7:30 PM? Apparently he is one of two companies being interviewed. RedChip Companies will air interviews with Anixia Biosciences, Inc. (NASDAQ:ANIX) on the RedChip Small Stocks, Big Money show on Bloomberg TV Saturday, May 2, at 7 p.m. Eastern Time. Bloomberg TV is available in an estimated 73 million homes across the U.S.
1 · Reply
Pedelco
Pedelco Apr. 30 at 1:58 PM
$ANIX back to 5$
0 · Reply
Kher33
Kher33 Apr. 30 at 10:29 AM
$ANIX https://ir.anixa.com/press-releases/detail/1122
0 · Reply
KONGLIVES1
KONGLIVES1 Apr. 29 at 2:17 PM
$ANIX I would love to know where this information is on the Mexican patent available so I can read about it myself. Thank you. Enjoy the ride. 
1 · Reply
focafoca99
focafoca99 Apr. 29 at 2:01 PM
$ANIX received a Mexican patent covering its breast cancer vaccine technology, extending protection in that market into 2040.
0 · Reply